BGI SENTISTM Cancer+Discovery

The Power Of Knowing

The panel provides one of the most comprehensive and accurate Next Generation Sequencing (NGS) testing solution for the identification of

Clinically actionable mutations (somatic & genetic variants)

Discovery of novel variants (with important functions in cancer)

Whole Exon Coverage

Major genetic alterations

FDA & NCCN guideline drug recommendation

Why choose us?

Comprehensive

Robust

Affordable

For more information on BGI’s Cancer+ Discovery Test :